-   directed: true
    comment: Trilostane was withdrawn from the United States market in April 1994 | MESH:D000308 refers to higher term Adrenocortical Hyperfunction that includes Hypercortisolism
    graph:
        drug: Trilostane
        drugbank: DB:DB01108
        drug_mesh: MESH:C009954
        disease: Hypercortisolism
        disease_mesh: MESH:D000308
    links:
    -   key: decreases activity of
        source: MESH:C009954
        target: InterPro:IPR002225
    -   key: negatively regulates
        source: InterPro:IPR002225
        target: REACT:R-HSA-196071
    -   key: decreases abundance of
        source: REACT:R-HSA-196071
        target: MESH:D013256
    -   key: negatively regulates
        source: InterPro:IPR002225
        target: REACT:R-HSA-193993
    -   key: decreases abundance of
        source: REACT:R-HSA-193993
        target: MESH:D013256
    -   key: negatively regulates
        source: InterPro:IPR002225
        target: REACT:R-HSA-194002
    -   key: decreases abundance of
        source: REACT:R-HSA-194002
        target: MESH:D013256
    -   key: manifestation of
        source: MESH:D013256
        target: MESH:D000308
    multigraph: true
    nodes:
    -   id: MESH:C009954
        label: Drug
        name: Trilostane
    -   id: InterPro:IPR002225
        label: GeneFamily
        name: 3-beta-hydroxysteroid dehydrogenase/delta 5,4 ketosteroid isomerase
    -   id: REACT:R-HSA-196071
        label: Pathway
        name: Metabolism of steroid hormones
    -   id: REACT:R-HSA-193993
        label: Pathway
        name: Mineralocorticoid biosynthesis
    -   id: REACT:R-HSA-194002
        label: Pathway
        name: Glucocorticoid biosynthesis
    -   id: MESH:D013256
        label: ChemicalSubstance
        name: Steroids
    -   id: MESH:D000308
        label: Disease
        name: Hypercortisolism
    reference: https://go.drugbank.com/drugs/DB01108#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Trilostane
-   directed: true
    graph:
        drug: Calcium Phosphate
        drugbank: DB:DB11348
        drug_mesh: MESH:C020243
        disease: Osteoporosis
        disease_mesh: MESH:D010024
    links:
    -   key: derives into
        source: MESH:C020243
        target: MESH:D002118
    -   key: derives into
        source: MESH:C020243
        target: MESH:D010710
    -   key: increases activity of
        source: MESH:D002118
        target: InterPro:IPR000276
    -   key: decreases secretion of
        source: InterPro:IPR000276
        target: UniProt:P01270
    -   key: decreases abundance of
        source: UniProt:P01270
        target: MESH:D002112       
    -   key: decreases expression of
        source: MESH:D002112
        target: InterPro:IPR008250
    -   key: negatively regulates
        source: InterPro:IPR008250
        target: GO:0006816
    -   key: located in
        source: GO:0006816
        target: UBERON:0000945
    -   key: negatively regulates
        source: UBERON:0000945
        target: GO:0045453
    -   key: decreases expression of
        source: MESH:D002112
        target: UniProt:Q9H1D0
    -   key: negatively regulates
        source: UniProt:Q9H1D0
        target: GO:0006816
    -   key: decreases expression of
        source: MESH:D002112
        target: UniProt:Q9NQA5
    -   key: negatively regulates
        source: UniProt:Q9NQA5
        target: GO:0006816
    -   key: located in
        source: GO:0006816
        target: UBERON:0002113
    -   key: negatively regulates
        source: UBERON:0002113
        target: GO:0045453
    -   key: positively regulates
        source: UniProt:P01270
        target: UniProt:P06881
    -   key: negatively regulates
        source: UniProt:P06881
        target: GO:0045453
    -   key: negatively regulates
        source: UniProt:P01270
        target: GO:0006816
    -   key: located in
        source: GO:0006816
        target: CL:0000137
    -   key: negatively regulates
        source: CL:0000137
        target: GO:0045453
    -   key: positively regulates
        source: GO:0045453
        target: GO:0055074
    -   key: positively regulates
        source: MESH:D010710
        target: GO:0055074
    -   key: manifestation of
        source: GO:0055074
        target: MESH:D010024
    multigraph: true
    nodes:
    -   id: MESH:C020243
        label: Drug
        name: Calcium Phosphate
    -   id: MESH:D002118
        label: ChemicalSubstance
        name: Calcium
    -   id: InterPro:IPR000276
        label: GeneFamily
        name: G protein-coupled receptor
    -   id: UniProt:P01270
        label: Protein
        name: Parathyroid hormone
    -   id: GO:0006816
        label: BiologicalProcess
        name: Calcium ion transport
    -   id: MESH:D010710
        label: ChemicalSubstance
        name: Phosphate
    -   id: MESH:D002112
        label: ChemicalSubstance
        name: Calcidiol
    -   id: InterPro:IPR008250
        label: GeneFamily
        name: Calcium dependent ATPases
    -   id: UBERON:0000945
        label: GrossAnatomicalStructure
        name: Gut
    -   id: UniProt:Q9H1D0
        label: Protein
        name: Transient receptor potential cation channel subfamily V member 6 (TRPV6)   
    -   id: UniProt:Q9NQA5
        label: Protein
        name: Transient receptor potential cation channel subfamily V member 5 (TRPV5) 
    -   id: UBERON:0002113
        label: GrossAnatomicalStructure
        name: Kidney
    -   id: UniProt:P06881
        label: Protein
        name: Calcitonin      
    -   id: CL:0000137
        label: Cell
        name: Osteocyte
    -   id: GO:0045453
        label: BiologicalProcess
        name: Bone resorption
    -   id: GO:0055074
        label: BiologicalProcess
        name: Calcium ion homeostasis
    -   id: MESH:D010024
        label: Disease
        name: Osteoporosis
    reference: https://go.drugbank.com/drugs/DB11348#mechanismofaction
-   directed: true
    graph:
        drug: Calcium Phosphate
        drugbank: DB:DB11348
        drug_mesh: MESH:C020243
        disease: Hypocalcemia
        disease_mesh: MESH:D006996
    links:
    -   key: derives into
        source: MESH:C020243
        target: MESH:D002118
    -   key: derives into
        source: MESH:C020243
        target: MESH:D010710
    -   key: increases activity of
        source: MESH:D002118
        target: InterPro:IPR000276
    -   key: decreases secretion of
        source: InterPro:IPR000276
        target: UniProt:P01270
    -   key: decreases abundance of
        source: UniProt:P01270
        target: MESH:D002112       
    -   key: decreases expression of
        source: MESH:D002112
        target: InterPro:IPR008250
    -   key: negatively regulates
        source: InterPro:IPR008250
        target: GO:0006816
    -   key: located in
        source: GO:0006816
        target: UBERON:0000945
    -   key: negatively regulates
        source: UBERON:0000945
        target: GO:0045453
    -   key: decreases expression of
        source: MESH:D002112
        target: UniProt:Q9H1D0
    -   key: negatively regulates
        source: UniProt:Q9H1D0
        target: GO:0006816
    -   key: decreases expression of
        source: MESH:D002112
        target: UniProt:Q9NQA5
    -   key: negatively regulates
        source: UniProt:Q9NQA5
        target: GO:0006816
    -   key: located in
        source: GO:0006816
        target: UBERON:0002113
    -   key: negatively regulates
        source: UBERON:0002113
        target: GO:0045453
    -   key: positively regulates
        source: UniProt:P01270
        target: UniProt:P06881
    -   key: negatively regulates
        source: UniProt:P06881
        target: GO:0045453
    -   key: negatively regulates
        source: UniProt:P01270
        target: GO:0006816
    -   key: located in
        source: GO:0006816
        target: CL:0000137
    -   key: negatively regulates
        source: CL:0000137
        target: GO:0045453
    -   key: positively regulates
        source: GO:0045453
        target: GO:0055074
    -   key: positively regulates
        source: MESH:D010710
        target: GO:0055074
    -   key: manifestation of
        source: GO:0055074
        target: MESH:D006996
    multigraph: true
    nodes:
    -   id: MESH:C020243
        label: Drug
        name: Calcium Phosphate
    -   id: MESH:D002118
        label: ChemicalSubstance
        name: Calcium
    -   id: InterPro:IPR000276
        label: GeneFamily
        name: G protein-coupled receptor
    -   id: UniProt:P01270
        label: Protein
        name: Parathyroid hormone
    -   id: GO:0006816
        label: BiologicalProcess
        name: Calcium ion transport
    -   id: MESH:D010710
        label: ChemicalSubstance
        name: Phosphate
    -   id: MESH:D002112
        label: ChemicalSubstance
        name: Calcidiol
    -   id: InterPro:IPR008250
        label: GeneFamily
        name: Calcium dependent ATPases
    -   id: UBERON:0000945
        label: GrossAnatomicalStructure
        name: Gut
    -   id: UniProt:Q9H1D0
        label: Protein
        name: Transient receptor potential cation channel subfamily V member 6 (TRPV6)   
    -   id: UniProt:Q9NQA5
        label: Protein
        name: Transient receptor potential cation channel subfamily V member 5 (TRPV5) 
    -   id: UBERON:0002113
        label: GrossAnatomicalStructure
        name: Kidney
    -   id: UniProt:P06881
        label: Protein
        name: Calcitonin      
    -   id: CL:0000137
        label: Cell
        name: Osteocyte
    -   id: GO:0045453
        label: BiologicalProcess
        name: Bone resorption
    -   id: GO:0055074
        label: BiologicalProcess
        name: Calcium ion homeostasis
    -   id: MESH:D006996
        label: Disease
        name: Hypocalcemia
    reference: https://go.drugbank.com/drugs/DB11348#mechanismofaction
-   directed: true
    graph:
        drug: Calcium Phosphate
        drugbank: DB:DB11348
        drug_mesh: MESH:C020243
        disease: Postmenopausal osteoporosis
        disease_mesh: MESH:D015663
    links:
    -   key: derives into
        source: MESH:C020243
        target: MESH:D002118
    -   key: derives into
        source: MESH:C020243
        target: MESH:D010710
    -   key: increases activity of
        source: MESH:D002118
        target: InterPro:IPR000276
    -   key: decreases secretion of
        source: InterPro:IPR000276
        target: UniProt:P01270
    -   key: decreases abundance of
        source: UniProt:P01270
        target: MESH:D002112       
    -   key: decreases expression of
        source: MESH:D002112
        target: InterPro:IPR008250
    -   key: negatively regulates
        source: InterPro:IPR008250
        target: GO:0006816
    -   key: located in
        source: GO:0006816
        target: UBERON:0000945
    -   key: negatively regulates
        source: UBERON:0000945
        target: GO:0045453
    -   key: decreases expression of
        source: MESH:D002112
        target: UniProt:Q9H1D0
    -   key: negatively regulates
        source: UniProt:Q9H1D0
        target: GO:0006816
    -   key: decreases expression of
        source: MESH:D002112
        target: UniProt:Q9NQA5
    -   key: negatively regulates
        source: UniProt:Q9NQA5
        target: GO:0006816
    -   key: located in
        source: GO:0006816
        target: UBERON:0002113
    -   key: negatively regulates
        source: UBERON:0002113
        target: GO:0045453
    -   key: positively regulates
        source: UniProt:P01270
        target: UniProt:P06881
    -   key: negatively regulates
        source: UniProt:P06881
        target: GO:0045453
    -   key: negatively regulates
        source: UniProt:P01270
        target: GO:0006816
    -   key: located in
        source: GO:0006816
        target: CL:0000137
    -   key: negatively regulates
        source: CL:0000137
        target: GO:0045453
    -   key: positively regulates
        source: GO:0045453
        target: GO:0055074
    -   key: positively regulates
        source: MESH:D010710
        target: GO:0055074
    -   key: manifestation of
        source: GO:0055074
        target: MESH:D015663
    multigraph: true
    nodes:
    -   id: MESH:C020243
        label: Drug
        name: Calcium Phosphate
    -   id: MESH:D002118
        label: ChemicalSubstance
        name: Calcium
    -   id: InterPro:IPR000276
        label: GeneFamily
        name: G protein-coupled receptor
    -   id: UniProt:P01270
        label: Protein
        name: Parathyroid hormone
    -   id: GO:0006816
        label: BiologicalProcess
        name: Calcium ion transport
    -   id: MESH:D010710
        label: ChemicalSubstance
        name: Phosphate
    -   id: MESH:D002112
        label: ChemicalSubstance
        name: Calcidiol
    -   id: InterPro:IPR008250
        label: GeneFamily
        name: Calcium dependent ATPases
    -   id: UBERON:0000945
        label: GrossAnatomicalStructure
        name: Gut
    -   id: UniProt:Q9H1D0
        label: Protein
        name: Transient receptor potential cation channel subfamily V member 6 (TRPV6)   
    -   id: UniProt:Q9NQA5
        label: Protein
        name: Transient receptor potential cation channel subfamily V member 5 (TRPV5) 
    -   id: UBERON:0002113
        label: GrossAnatomicalStructure
        name: Kidney
    -   id: UniProt:P06881
        label: Protein
        name: Calcitonin      
    -   id: CL:0000137
        label: Cell
        name: Osteocyte
    -   id: GO:0045453
        label: BiologicalProcess
        name: Bone resorption
    -   id: GO:0055074
        label: BiologicalProcess
        name: Calcium ion homeostasis
    -   id: MESH:D015663
        label: Disease
        name: Postmenopausal osteoporosis
    reference: https://go.drugbank.com/drugs/DB11348#mechanismofaction
-   directed: true
    comment: Trientine is the salt form of Triethylenetetramine (DB06824)
    graph:
        drug: Trientine
        drugbank: DB:DB06824
        drug_mesh: MESH:D014266
        disease: Wilson's disease
        disease_mesh: MESH:D006527
    links:
    -   key: molecularly interacts with
        source: MESH:D014266
        target: MESH:D003300
    -   key: positively regulates
        source: MESH:D003300
        target: GO:0055070
    -   key: manifestation of
        source: GO:0055070
        target: MESH:D006527
    multigraph: true
    nodes:
    -   id: MESH:D014266
        label: Drug
        name: Trientine
    -   id: MESH:D003300
        label: ChemicalSubstance
        name: Copper
    -   id: GO:0055070
        label: BiologicalProcess
        name: Copper ion homeostasis
    -   id: MESH:D006527
        label: Disease
        name: Wilson's disease
    reference: https://go.drugbank.com/drugs/DB06824#mechanismofaction DOI:10.1158/1535-7163.MCT-10-0523 https://pubchem.ncbi.nlm.nih.gov/compound/Trientine-hydrochloride#section=Pharmacology-and-Biochemistry
-   directed: true
    comment: Trientine is the salt form of Triethylenetetramine (DB06824)
    graph:
        drug: Trientine
        drugbank: DB:DB06824
        drug_mesh: MESH:D014266
        disease: Renal cell carcinoma
        disease_mesh: MESH:D002292
    links:
    -   key: molecularly interacts with
        source: MESH:D014266
        target: MESH:D054856
    -   key: decreases activity of
        source: MESH:D054856
        target: InterPro:IPR003545
    -   key: negatively regulates
        source: InterPro:IPR003545
        target: GO:0016049
    -   key: located in
        source: GO:0016049
        target: CL:0001063 
    -   key: causes
        source: CL:0001063 
        target: MESH:D002292
    multigraph: true
    nodes:
    -   id: MESH:D014266
        label: Drug
        name: Trientine
    -   id: MESH:D054856
        label: ChemicalSubstance
        name: G-quadruplex
    -   id: InterPro:IPR003545
        label: GeneFamily
        name: Telomerase
    -   id: GO:0016049
        label: BiologicalProcess
        name: Cell growth
    -   id: CL:0001063 
        label: Cell
        name: Tumor cell
    -   id: MESH:D002292
        label: Disease
        name: Renal cell carcinoma
    reference: https://go.drugbank.com/drugs/DB06824#mechanismofaction DOI:10.1158/1535-7163.MCT-10-0523 https://pubchem.ncbi.nlm.nih.gov/compound/Trientine-hydrochloride#section=Pharmacology-and-Biochemistry
-   directed: true
    comment: Trientine is the salt form of Triethylenetetramine (DB06824)
    graph:
        drug: Trientine
        drugbank: DB:DB06824
        drug_mesh: MESH:D014266
        disease: Renal cell carcinoma
        disease_mesh: MESH:D002292
    links:
    -   key: molecularly interacts with
        source: MESH:D014266
        target: MESH:D003300
    -   key: decreases activity of
        source: MESH:D003300
        target: InterPro:IPR000072
    -   key: negatively regulates
        source: InterPro:IPR000072
        target: GO:0001525
    -   key: decreases activity of
        source: MESH:D003300
        target: UniProt:P05230
    -   key: negatively regulates
        source: UniProt:P05230
        target: GO:0001525
    -   key: decreases activity of
        source: MESH:D003300
        target: InterPro:IPR000975
    -   key: negatively regulates
        source: InterPro:IPR000975
        target: GO:0001525
    -   key: decreases activity of
        source: MESH:D003300
        target: InterPro:PR003573
    -   key: negatively regulates
        source: InterPro:PR003573
        target: GO:0001525
    -   key: decreases activity of
        source: MESH:D003300
        target: UniProt:P10145
    -   key: negatively regulates
        source: UniProt:P10145
        target: GO:0001525
    -   key: decreases activity of
        source: MESH:D003300
        target: UniProt:P19838
    -   key: negatively regulates
        source: UniProt:P19838
        target: GO:0001525
    -   key: decreases activity of
        source: MESH:D003300
        target: UniProt:P00441
    -   key: negatively regulates
        source: UniProt:P00441
        target: GO:0001525
    -   key: located in
        source: GO:0001525
        target: CL:0001063 
    -   key: causes
        source: CL:0001063 
        target: MESH:D002292
    multigraph: true
    nodes:
    -   id: MESH:D014266
        label: Drug
        name: Trientine
    -   id: MESH:D003300
        label: ChemicalSubstance
        name: Copper
    -   id: InterPro:IPR000072
        label: GeneFamily
        name: Vascular endothelial growth factor-1
    -   id: UniProt:P00441
        label: Protein
        name: Superoxide dismutase 1
    -   id: UniProt:P19838
        label: Protein
        name: Nuclear factor kappa-light-chain-enhancer of activated B cells
    -   id: UniProt:P10145
        label: Protein
        name: Interleukin 8
    -   id: InterPro:PR003573
        label: GeneFamily
        name: Interleukin 6
    -   id: InterPro:IPR000975
        label: GeneFamily
        name: Interleukin 1
    -   id: UniProt:P05230
        label: Protein
        name: Fibroblast growth factor-1
    -   id: GO:0001525
        label: BiologicalProcess
        name: Angiogenesis
    -   id: CL:0001063 
        label: Cell
        name: Tumor cell
    -   id: MESH:D002292
        label: Disease
        name: Renal cell carcinoma
    reference: https://go.drugbank.com/drugs/DB06824#mechanismofaction DOI:10.1158/1535-7163.MCT-10-0523 https://pubchem.ncbi.nlm.nih.gov/compound/Trientine-hydrochloride#section=Pharmacology-and-Biochemistry
-   directed: true
    comment: Trientine is the salt form of Triethylenetetramine (DB06824)
    graph:
        drug: Trientine
        drugbank: DB:DB06824
        drug_mesh: MESH:D014266
        disease: Renal cell carcinoma
        disease_mesh: MESH:D002292
    links:
    -   key: negatively regulates
        source: MESH:D014266
        target: REACT:R-HSA-6802957
    -   key: causes
        source: REACT:R-HSA-6802957
        target: GO:0012501
    -   key: molecularly interacts with
        source: MESH:D014266
        target: MESH:D003300
    -   key: increases abundance of
        source: MESH:D003300
        target: MESH:D000975
    -   key: causes
        source: MESH:D000975
        target: GO:0012501       
    -   key: located in
        source: GO:0012501
        target: CL:0001063 
    -   key: causes
        source: CL:0001063 
        target: MESH:D002292
    multigraph: true
    nodes:
    -   id: MESH:D014266
        label: Drug
        name: Trientine
    -   id: REACT:R-HSA-6802957
        label: Pathway
        name: Oncogenic MAPK signaling
    -   id: MESH:D003300
        label: ChemicalSubstance
        name: Copper
    -   id: MESH:D000975
        label: ChemicalSubstance
        name: Antioxidants
    -   id: GO:0012501
        label: BiologicalProcess
        name: Apoptosis
    -   id: CL:0001063 
        label: Cell
        name: Tumor cell
    -   id: MESH:D002292
        label: Disease
        name: Renal cell carcinoma
    reference: https://go.drugbank.com/drugs/DB06824#mechanismofaction DOI:10.1158/1535-7163.MCT-10-0523 https://pubchem.ncbi.nlm.nih.gov/compound/Trientine-hydrochloride#section=Pharmacology-and-Biochemistry
-   directed: true
    comment: Sulfamethoxazole is given in combination with trimethoprim
    graph:
        drug: Sulfamethoxazole
        drugbank: DB:DB01015
        drug_mesh: MESH:D013420
        disease: Nocardiosis
        disease_mesh: MESH:D009617
    links:
    -   key: decreases activity of
        source: MESH:D013420
        target: UniProt:U5EHR3
    -   key: decreases abundance of
        source: UniProt:U5EHR3
        target: MESH:D005492
    -   key: prevents
        source: MESH:D005492
        target: GO:0071897
    -   key: in taxon
        source: GO:0071897
        target: NCBITaxon:1824
    -   key: causes
        source: NCBITaxon:1824
        target: MESH:D009617
    multigraph: true
    nodes:
    -   id: MESH:D013420
        label: Drug
        name: Sulfamethoxazole
    -   id: UniProt:U5EHR3
        label: Protein
        name: Dihydropteroate synthase
    -   id: MESH:D005492
        label: ChemicalSubstance
        name: Folic acid
    -   id: GO:0071897
        label: BiologicalProcess
        name: DNA synthesis
    -   id: NCBITaxon:1824
        label: OrganismTaxon
        name: Nocardia asteroides 
    -   id: MESH:D009617
        label: Disease
        name: Nocardiosis
    reference: https://go.drugbank.com/drugs/DB01015#mechanismofaction https://en.wikipedia.org/wiki/Sulfamethoxazole
-   directed: true
    comment: Sulfamethoxazole is given in combination with trimethoprim
    graph:
        drug: Sulfamethoxazole
        drugbank: DB:DB01015
        drug_mesh: MESH:D013420
        disease: Shigellosis
        disease_mesh: MESH:D004405
    links:
    -   key: decreases activity of
        source: MESH:D013420
        target: UniProt:A0A3C0GZY2
    -   key: decreases abundance of
        source: UniProt:A0A3C0GZY2
        target: MESH:D005492
    -   key: prevents
        source: MESH:D005492
        target: GO:0071897
    -   key: in taxon
        source: GO:0071897
        target: NCBITaxon:543
    -   key: causes
        source: NCBITaxon:543
        target: MESH:D004405
    multigraph: true
    nodes:
    -   id: MESH:D013420
        label: Drug
        name: Sulfamethoxazole
    -   id: UniProt:A0A3C0GZY2
        label: Protein
        name: Dihydropteroate synthase
    -   id: MESH:D005492
        label: ChemicalSubstance
        name: Folic acid
    -   id: GO:0071897
        label: BiologicalProcess
        name: DNA synthesis
    -   id: NCBITaxon:543
        label: OrganismTaxon
        name: Enterobacteriaceae
    -   id: MESH:D004405
        label: Disease
        name: Shigellosis
    reference: https://go.drugbank.com/drugs/DB01015#mechanismofaction https://en.wikipedia.org/wiki/Sulfamethoxazole
-   directed: true
    comment: Sulfamethoxazole is given in combination with trimethoprim
    graph:
        drug: Sulfamethoxazole
        drugbank: DB:DB01015
        drug_mesh: MESH:D013420
        disease: Toxoplasmosis
        disease_mesh: MESH:D014123
    links:
    -   key: decreases activity of
        source: MESH:D013420
        target: UniProt:Q4U207
    -   key: decreases abundance of
        source: UniProt:Q4U207
        target: MESH:D005492
    -   key: prevents
        source: MESH:D005492
        target: GO:0071897
    -   key: in taxon
        source: GO:0071897
        target: NCBITaxon:5811
    -   key: causes
        source: NCBITaxon:5811
        target: MESH:D014123
    multigraph: true
    nodes:
    -   id: MESH:D013420
        label: Drug
        name: Sulfamethoxazole
    -   id: UniProt:Q4U207
        label: Protein
        name: Dihydropteroate synthase
    -   id: MESH:D005492
        label: ChemicalSubstance
        name: Folic acid
    -   id: GO:0071897
        label: BiologicalProcess
        name: DNA synthesis
    -   id: NCBITaxon:5811
        label: OrganismTaxon
        name: Toxoplasma gondii
    -   id: MESH:D014123
        label: Disease
        name: Toxoplasmosis
    reference: https://go.drugbank.com/drugs/DB01015#mechanismofaction https://en.wikipedia.org/wiki/Sulfamethoxazole
-   directed: true
    comment: Sulfamethoxazole is given in combination with trimethoprim
    graph:
        drug: Sulfamethoxazole
        drugbank: DB:DB01015
        drug_mesh: MESH:D013420
        disease: Chlamydial conjunctivitis
        disease_mesh: MESH:D003235
    links:
    -   key: decreases activity of
        source: MESH:D013420
        target: UniProt:A0A655MZZ2
    -   key: decreases abundance of
        source: UniProt:A0A655MZZ2
        target: MESH:D005492
    -   key: prevents
        source: MESH:D005492
        target: GO:0071897
    -   key: in taxon
        source: GO:0071897
        target: NCBITaxon:813
    -   key: causes
        source: NCBITaxon:813
        target: MESH:D003235
    multigraph: true
    nodes:
    -   id: MESH:D013420
        label: Drug
        name: Sulfamethoxazole
    -   id: UniProt:A0A655MZZ2
        label: Protein
        name: Dihydropteroate synthase
    -   id: MESH:D005492
        label: ChemicalSubstance
        name: Folic acid
    -   id: GO:0071897
        label: BiologicalProcess
        name: DNA synthesis
    -   id: NCBITaxon:813
        label: OrganismTaxon
        name: Chlamydia trachomatis
    -   id: MESH:D003235
        label: Disease
        name: Chlamydial conjunctivitis
    reference: https://go.drugbank.com/drugs/DB01015#mechanismofaction https://en.wikipedia.org/wiki/Sulfamethoxazole
-   directed: true
    graph:
        drug: Penciclovir
        drugbank: DB:DB00299
        drug_mesh: MESH:C053539
        disease: Herpes labialis
        disease_mesh: MESH:D006560
    links:
    -   key: increases abundance of
        source: MESH:C053539
        target: MESH:C092310
    -   key: decreases molecular interaction
        source: MESH:C092310
        target: MESH:C029603
    -   key: decreases activity of
        source: MESH:C029603
        target: UniProt:Q99FY1
    -   key: prevents
        source: UniProt:Q99FY1
        target: GO:0019079
    -   key: in taxon
        source: GO:0019079
        target: NCBITaxon:10292
    -   key: causes
        source: NCBITaxon:10292
        target: MESH:D006560
    multigraph: true
    nodes:
    -   id: MESH:C053539
        label: Drug
        name: Penciclovir
    -   id: MESH:C092310
        label: ChemicalSubstance
        name: Penciclovir triphosphate
    -   id: MESH:C029603
        label: ChemicalSubstance
        name: Deoxyguanosine triphosphate 
    -   id: UniProt:Q99FY1
        label: Protein
        name: Viral DNA polymerase
    -   id: GO:0019079
        label: BiologicalProcess
        name: Viral replication
    -   id: NCBITaxon:10292
        label: OrganismTaxon
        name: Herpesviridae
    -   id: MESH:D006560
        label: Disease
        name: Herpes labialis
    reference: https://go.drugbank.com/drugs/DB00299#mechanismofaction
-   directed: true
    graph:
        drug: Axitinib
        drugbank: DB:DB06626
        drug_mesh: NULL
        disease: Renal cell carcinoma
        disease_mesh: MESH:D002292
    links:
    -   key: decreases activity of
        source: DB:DB06626
        target: UniProt:P17948
    -   key: negatively regulates
        source: UniProt:P17948
        target: GO:0001525
    -   key: decreases activity of
        source: DB:DB06626
        target: UniProt:P35968
    -   key: negatively regulates
        source: UniProt:P35968
        target: GO:0001525
    -   key: decreases activity of
        source: DB:DB06626
        target: UniProt:P35916
    -   key: negatively regulates
        source: UniProt:P35916
        target: GO:0001525
    -   key: decreases activity of
        source: DB:DB06626
        target: InterPro:IPR006782
    -   key: negatively regulates
        source: InterPro:IPR006782
        target: GO:0001525
    -   key: decreases activity of
        source: DB:DB06626
        target: UniProt:P10721
    -   key: negatively regulates
        source: UniProt:P10721
        target: GO:0001525
    -   key: located in
        source: GO:0001525
        target: CL:0001063 
    -   key: causes
        source: CL:0001063 
        target: MESH:D002292
    multigraph: true
    nodes:
    -   id: DB:DB06626
        label: Drug
        name: Axitinib
    -   id: UniProt:P17948
        label: Protein
        name: Vascular endothelial growth factor receptor 1
    -   id: UniProt:P35968
        label: Protein
        name: Vascular endothelial growth factor receptor 2
    -   id: UniProt:P35916
        label: Protein
        name: Vascular endothelial growth factor receptor 3
    -   id: InterPro:IPR006782
        label: GeneFamily
        name: Platelet-derived growth factor receptor
    -   id: UniProt:P10721
        label: Protein
        name: c-Kit
    -   id: GO:0001525
        label: BiologicalProcess
        name: Angiogenesis
    -   id: CL:0001063 
        label: Cell
        name: Tumor cell
    -   id: MESH:D002292
        label: Disease
        name: Renal cell carcinoma
    reference: https://go.drugbank.com/drugs/DB06626#mechanismofaction https://en.wikipedia.org/wiki/Axitinib
-   directed: true
    graph:
        drug: Azelaic acid
        drugbank: DB:DB00548
        drug_mesh: MESH:C010038
        disease: Rosacea
        disease_mesh: MESH:D012393
    links:
    -   key: increases degradation of
        source: MESH:C010038
        target: MESH:D017382
    -   key: negatively regulates
        source: MESH:D017382
        target: GO:0006954
    -   key: correlated with
        source: GO:0006954
        target: MESH:D012393
    multigraph: true
    nodes:
    -   id: MESH:C010038
        label: Drug
        name: Azelaic acid
    -   id: MESH:D017382
        label: ChemicalSubstance
        name: Free oxygen radical
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammation
    -   id: MESH:D012393
        label: Disease
        name: Rosacea
    reference: https://go.drugbank.com/drugs/DB00548#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Azelaic-acid https://en.wikipedia.org/wiki/Azelaic_acid
-   directed: true
    graph:
        drug: Azelaic acid
        drugbank: DB:DB00548
        drug_mesh: MESH:C010038
        disease: Acne vulgaris
        disease_mesh: MESH:D000152
    links:
    -   key: decreases activity of
        source: MESH:C010038
        target: UBERON:0001821
    -   key: prevents
        source: UBERON:0001821
        target: GO:0006096
    -   key: negatively regulates
        source: GO:0006096
        target: GO:0016049
    -   key: in taxon
        source: GO:0016049
        target: NCBITaxon:1747
    -   key: causes
        source: NCBITaxon:1747
        target: MESH:D000152
    multigraph: true
    nodes:
    -   id: MESH:C010038
        label: Drug
        name: Azelaic acid
    -   id: UBERON:0001821
        label: GrossAnatomicalStructure
        name: Sebaceous Gland
    -   id: GO:0006096
        label: BiologicalProcess
        name: Glycolytic process
    -   id: GO:0016049
        label: BiologicalProcess
        name: Cell growth
    -   id: NCBITaxon:1747
        label: OrganismTaxon
        name: Propionibacterium acnes
    -   id: MESH:D000152
        label: Disease
        name: Acne vulgaris
    reference: https://go.drugbank.com/drugs/DB00548#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Azelaic-acid https://en.wikipedia.org/wiki/Azelaic_acid
-   directed: true
    graph:
        drug: Azelaic acid
        drugbank: DB:DB00548
        drug_mesh: MESH:C010038
        disease: Acne vulgaris
        disease_mesh: MESH:D000152
    links:
    -   key: decreases activity of
        source: MESH:C010038
        target: UBERON:0001821
    -   key: decreases activity of
        source: UBERON:0001821
        target: UniProt:A0A7C6MFF9
    -   key: negatively regulates
        source: UniProt:A0A7C6MFF9
        target: GO:0016049
    -   key: decreases activity of
        source: UBERON:0001821
        target: UniProt:D4HBV0
    -   key: negatively regulates
        source: UniProt:D4HBV0
        target: GO:0016049
    -   key: decreases activity of
        source: UBERON:0001821
        target: UniProt:D4HCU8
    -   key: negatively regulates
        source: UniProt:D4HCU8
        target: GO:0016049
    -   key: in taxon
        source: GO:0016049
        target: NCBITaxon:1282
    -   key: causes
        source: NCBITaxon:1282
        target: MESH:D000152
    multigraph: true
    nodes:
    -   id: MESH:C010038
        label: Drug
        name: Azelaic acid
    -   id: UBERON:0001821
        label: GrossAnatomicalStructure
        name: Sebaceous Gland
    -   id: UniProt:A0A7C6MFF9
        label: Protein
        name: Tyrosinase
    -   id: UniProt:D4HCU8
        label: Protein
        name: DNA polymerase
    -   id: UniProt:D4HBV0 
        label: Protein
        name: Thioredoxin reductase        
    -   id: GO:0016049
        label: BiologicalProcess
        name: Cell growth
    -   id: NCBITaxon:1282
        label: OrganismTaxon
        name: Staphylococcus epidermidis
    -   id: MESH:D000152
        label: Disease
        name: Acne vulgaris
    reference: https://go.drugbank.com/drugs/DB00548#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Azelaic-acid https://en.wikipedia.org/wiki/Azelaic_acid
-   directed: true
    graph:
        drug: Azelaic acid
        drugbank: DB:DB00548
        drug_mesh: MESH:C010038
        disease: Acne vulgaris
        disease_mesh: MESH:D000152
    links:
    -   key: increases degradation of
        source: MESH:C010038
        target: MESH:D017382
    -   key: negatively regulates
        source: MESH:D017382
        target: GO:0006954
    -   key: correlated with
        source: GO:0006954
        target: MESH:D000152
    multigraph: true
    nodes:
    -   id: MESH:C010038
        label: Drug
        name: Azelaic acid
    -   id: MESH:D017382
        label: ChemicalSubstance
        name: Free oxygen radical
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammation
    -   id: MESH:D000152
        label: Disease
        name: Acne vulgaris
    reference: https://go.drugbank.com/drugs/DB00548#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Azelaic-acid https://en.wikipedia.org/wiki/Azelaic_acid
-   directed: true
    graph:
        drug: Ceftibuten
        drugbank: DB:DB01415
        drug_mesh: NULL
        disease: Tonsillitis
        disease_mesh: MESH:D014069
    links:
    -   key: decreases activity of
        source: DB:DB01415
        target: UniProt:Q54906
    -   key: prevents
        source: UniProt:Q54906
        target: GO:0018104
    -   key: negatively regulates
        source: GO:0018104
        target: GO:0042546
    -   key: in taxon
        source: GO:0042546
        target: NCBITaxon:1314
    -   key: causes
        source: NCBITaxon:1314
        target: MESH:D014069
    multigraph: true
    nodes:
    -   id: DB:DB01415
        label: Drug
        name: Ceftibuten
    -   id: UniProt:Q54906
        label: Protein
        name: Penicillin-binding proteins
    -   id: GO:0018104
        label: BiologicalProcess
        name: Peptidoglycan-protein cross-linking
    -   id: GO:0042546
        label: BiologicalProcess
        name: Cell-wall synthesis
    -   id: NCBITaxon:1314
        label: OrganismTaxon
        name: Streptococcus pyogenes
    -   id: MESH:D014069
        label: Disease
        name: Tonsillitis
    reference: https://go.drugbank.com/drugs/DB01415#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/5282242
-   directed: true
    graph:
        drug: Ceftibuten
        drugbank: DB:DB01415
        drug_mesh: NULL
        disease: Streptococcus pyogenes infection
        disease_mesh: MESH:D013290
    links:
    -   key: decreases activity of
        source: DB:DB01415
        target: UniProt:Q54906
    -   key: prevents
        source: UniProt:Q54906
        target: GO:0018104
    -   key: negatively regulates
        source: GO:0018104
        target: GO:0042546
    -   key: in taxon
        source: GO:0042546
        target: NCBITaxon:1314
    -   key: causes
        source: NCBITaxon:1314
        target: MESH:D013290
    multigraph: true
    nodes:
    -   id: DB:DB01415
        label: Drug
        name: Ceftibuten
    -   id: UniProt:Q54906
        label: Protein
        name: Penicillin-binding proteins
    -   id: GO:0018104
        label: BiologicalProcess
        name: Peptidoglycan-protein cross-linking
    -   id: GO:0042546
        label: BiologicalProcess
        name: Cell-wall synthesis
    -   id: NCBITaxon:1314
        label: OrganismTaxon
        name: Streptococcus pyogenes
    -   id: MESH:D013290
        label: Disease
        name: Streptococcus pyogenes infection
    reference: https://go.drugbank.com/drugs/DB01415#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/5282242
-   directed: true
    graph:
        drug: Difenoxin
        drugbank: DB:DB01501
        drug_mesh: MESH:C100010
        disease: Diarrhea
        disease_mesh: MESH:D003967
    links:
    -   key: increases activity of
        source: MESH:C100010
        target: InterPro:IPR001418
    -   key: located in
        source: InterPro:IPR001418
        target: UBERON:0012453
    -   key: negatively regulates
        source: UBERON:0012453
        target: GO:0061526
    -   key: regulates
        source: GO:0061526
        target: GO:0120054
    -   key: correlated with
        source: GO:0120054
        target: MESH:D003967
    multigraph: true
    nodes:
    -   id: MESH:C100010
        label: Drug
        name: Difenoxin
    -   id: InterPro:IPR001418
        label: GeneFamily
        name: Opioid receptors
    -   id: UBERON:0012453
        label: GrossAnatomicalStructure
        name: Peripheral nerve terminal
    -   id: GO:0061526
        label: GrossAnatomicalStructure
        name: Release of acetylcholine
    -   id: GO:0120054
        label: GrossAnatomicalStructure
        name: Intestinal motility
    -   id: MESH:D003967
        label: Disease
        name: Diarrhea
    reference: https://go.drugbank.com/drugs/DB01501#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Difenoxin#section=Pharmacology
-   directed: true
    graph:
        drug: Gonadorelin
        drugbank: DB:DB00644
        drug_mesh: MESH:D007987
        disease: Amenorrhea
        disease_mesh: MESH:D000568
    links:
    -   key: increases activity of
        source: MESH:D007987
        target: UniProt:P30968
    -   key: positively regulates
        source: UniProt:P30968
        target: GO:0046884
    -   key: location of
        source: GO:0046884
        target: UBERON:0000007
    -   key: positively regulates
        source: UniProt:P30968
        target: GO:0032275
    -   key: location of
        source: GO:0032275
        target: UBERON:0000007
    -   key: produces
        source: UBERON:0000007
        target: MESH:D012739
    -   key: manifestation of
        source: MESH:D012739
        target: MESH:D000568
    multigraph: true
    nodes:
    -   id: MESH:D007987
        label: Drug
        name: Gonadorelin
    -   id: UniProt:P30968
        label: Protein
        name: Gonadotropin-releasing hormone receptor
    -   id: GO:0032275
        label: BiologicalProcess
        name: Luteinizing hormone secretion         
    -   id: GO:0046884
        label: BiologicalProcess
        name: Follicle-stimulating hormone secretion 
    -   id: UBERON:0000007
        label: GrossAnatomicalStructure
        name: Pituitary gland
    -   id: MESH:D012739
        label: ChemicalSubstance
        name: Gonadal Steroid Hormones
    -   id: MESH:D000568
        label: Disease
        name: Amenorrhea
    reference: https://go.drugbank.com/drugs/DB00644#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Gonadorelin
-   directed: true
    graph:
        drug: Icosapent ethyl
        drugbank: DB:DB08887
        drug_mesh: NULL
        disease: Hypertriglyceridemia
        disease_mesh: MESH:D015228
    links:
    -   key: decreases activity of
        source: DB:DB08887
        target: UniProt:O75907
    -   key: negatively regulates
        source: UniProt:O75907
        target: REACT:R-HSA-75109
    -   key: decreases abundance of
        source: REACT:R-HSA-75109
        target: MESH:D014280
    -   key: increases activity of
        source: DB:DB08887    
        target: UniProt:P06858
    -   key: located in
        source: UniProt:P06858
        target: UBERON:0000178
    -   key: increases degradation of
        source: UBERON:0000178
        target: MESH:D014280
    -   key: increases activity of
        source: DB:DB08887
        target: GO:0006635
    -   key: increases degradation of
        source: GO:0006635
        target: MESH:D014280
    -   key: manifestation of
        source: MESH:D014280
        target: MESH:D015228
    multigraph: true
    nodes:
    -   id: DB:DB08887
        label: Drug
        name: Icosapent ethyl
    -   id: UniProt:O75907
        label: Protein
        name: Diglyceride acyltransferase
    -   id: REACT:R-HSA-75109
        label: Pathway
        name: Triglyceride biosynthesis
    -   id: GO:0006635
        label: BiologicalProcess
        name: Fatty acid beta-oxidation
    -   id: UBERON:0000178
        label: GrossAnatomicalStructure
        name: Blood
    -   id: UniProt:P06858
        label: Protein
        name: Lipoprotein lipase
    -   id: MESH:D014280
        label: ChemicalSubstance
        name: Triglyceride
    -   id: MESH:D015228
        label: Disease
        name: Hypertriglyceridemia
    reference: https://go.drugbank.com/drugs/DB08887#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Icosapent-ethyl#section=Pharmacology-and-Biochemistry https://en.wikipedia.org/wiki/Ethyl_eicosapentaenoic_acid
-   directed: true
    graph:
        drug: Nicotinic acid
        drugbank: DB:DB00627
        drug_mesh: MESH:D009525
        disease: Vitamin deficiency
        disease_mesh: MESH:D001361
    links:
    -   key: part of
        source: MESH:D009525
        target: MESH:D019587
    -   key: ameliorates
        source: MESH:D019587
        target: MESH:D001361
    multigraph: true
    nodes:
    -   id: MESH:D009525
        label: Drug
        name: Nicotinic acid
    -   id: MESH:D019587
        label: ChemicalSubstance
        name: Dietary supplements
    -   id: MESH:D001361
        label: Disease
        name: Vitamin deficiency
    reference: https://go.drugbank.com/drugs/DB00627#mechanismofaction  https://en.wikipedia.org/wiki/Niacin#Mechanisms doi:10.1194/jlr.S092007
-   directed: true
    graph:
        drug: Nicotinic acid
        drugbank: DB:DB00627
        drug_mesh: MESH:D009525
        disease: Hypertriglyceridemia
        disease_mesh: MESH:D015228
    links:
    -   key: decreases activity of
        source: MESH:D009525
        target: UniProt:O75907
    -   key: negatively regulates
        source: UniProt:O75907
        target: REACT:R-HSA-75109
    -   key: decreases abundance of
        source: REACT:R-HSA-75109
        target: MESH:D014280
    -   key: manifestation of
        source: MESH:D014280
        target: MESH:D015228
    multigraph: true
    nodes:
    -   id: MESH:D009525
        label: Drug
        name: Nicotinic acid
    -   id: UniProt:O75907
        label: Protein
        name: Diglyceride acyltransferase
    -   id: REACT:R-HSA-75109
        label: Pathway
        name: Triglyceride biosynthesis
    -   id: MESH:D014280
        label: ChemicalSubstance
        name: Triglyceride
    -   id: MESH:D015228
        label: Disease
        name: Hypertriglyceridemia
    reference: https://go.drugbank.com/drugs/DB00627#mechanismofaction  https://en.wikipedia.org/wiki/Niacin#Mechanisms doi:10.1194/jlr.S092007

-   directed: true
    graph:
        drug: Nicotinic acid
        drugbank: DB:DB00627
        drug_mesh: MESH:D009525
        disease: Mixed hyperlipidemia
        disease_mesh: MESH:D006950
    links:
    -   key: decreases activity of
        source: MESH:D009525
        target: UniProt:O75907
    -   key: negatively regulates
        source: UniProt:O75907
        target: REACT:R-HSA-75109
    -   key: decreases abundance of
        source: REACT:R-HSA-75109
        target: MESH:D014280
    -   key: increases activity of
        source: MESH:D009525
        target: UniProt:Q8TDS4
    -   key: decreases synthesis of
        source: UniProt:Q8TDS4
        target: MESH:D000242
    -   key: decreases abundance of
        source: MESH:D000242
        target: MESH:D005230
    -   key: decreases expression of
        source: MESH:D005230
        target: UniProt:P02656
    -   key: decreases synthesis of
        source: UniProt:P02656
        target: MESH:D008074
    -   key: decreases expression of
        source: MESH:D005230
        target: UniProt:Q86YN6
    -   key: decreases synthesis of
        source: UniProt:Q86YN6
        target: MESH:D008074
    -   key: increases activity of
        source: MESH:D009525
        target: UniProt:P49019
    -   key: decreases synthesis of
        source: UniProt:P49019
        target: MESH:D000242
    -   key: decreases degradation of
        source: MESH:D009525
        target: UniProt:P02647
    -   key: increases abundance of
        source: UniProt:P02647
        target: MESH:D008076
    -   key: manifestation of
        source: MESH:D008076
        target: MESH:D006950
    -   key: increases degradation of
        source: MESH:D014280
        target: UniProt:P04114
    -   key: decreases synthesis of
        source: UniProt:P04114
        target: MESH:D008074
    -   key: manifestation of
        source: MESH:D008074
        target: MESH:D006950
    multigraph: true
    nodes:
    -   id: MESH:D009525
        label: Drug
        name: Nicotinic acid
    -   id: UniProt:O75907
        label: Protein
        name: Diacylglycerol O-acyltransferase 2 (DGAT2)
    -   id: REACT:R-HSA-75109
        label: Pathway
        name: Triglyceride biosynthesis
    -   id: MESH:D014280
        label: ChemicalSubstance
        name: Triglyceride
    -   id: MESH:D008076
        label: ChemicalSubstance
        name: HDL Cholesterol
    -   id: UniProt:P02647
        label: Protein
        name: Apolipoprotein A1
    -   id: UniProt:P49019
        label: Protein
        name: Hydroxycarboxylic acid receptor 3
    -   id: UniProt:Q86YN6
        label: Protein
        name: PPARg coactivator-1b
    -   id: MESH:D008074
        label: ChemicalSubstance
        name: Lipoprotein
    -   id: UniProt:P02656
        label: Protein
        name: Apolipoprotein C3
    -   id: MESH:D005230
        label: ChemicalSubstance
        name: Free fatty acids
    -   id: MESH:D000242
        label: ChemicalSubstance
        name: Cyclic AMP
    -   id: UniProt:Q8TDS4
        label: Protein
        name: Hydroxycarboxylic acid receptor 2
    -   id: UniProt:P04114
        label: Protein
        name: Apolipoprotein B
    -   id: MESH:D008074
        label: ChemicalSubstance
        name: Lipoprotein
    -   id: MESH:D006950
        label: Disease
        name: Mixed hyperlipidemia
    reference: https://go.drugbank.com/drugs/DB00627#mechanismofaction  https://en.wikipedia.org/wiki/Niacin#Mechanisms doi:10.1194/jlr.S092007
-   directed: true
    graph:
        drug: Nicotinic acid
        drugbank: DB:DB00627
        drug_mesh: MESH:D009525
        disease: Hypercholesterolemia
        disease_mesh: MESH:D006937
    links:
    -   key: decreases activity of
        source: MESH:D009525
        target: UniProt:O75907
    -   key: negatively regulates
        source: UniProt:O75907
        target: REACT:R-HSA-75109
    -   key: decreases abundance of
        source: REACT:R-HSA-75109
        target: MESH:D014280
    -   key: increases activity of
        source: MESH:D009525
        target: UniProt:Q8TDS4
    -   key: decreases synthesis of
        source: UniProt:Q8TDS4
        target: MESH:D000242
    -   key: decreases abundance of
        source: MESH:D000242
        target: MESH:D005230
    -   key: decreases expression of
        source: MESH:D005230
        target: UniProt:P02656
    -   key: decreases synthesis of
        source: UniProt:P02656
        target: MESH:D008074
    -   key: decreases expression of
        source: MESH:D005230
        target: UniProt:Q86YN6
    -   key: decreases synthesis of
        source: UniProt:Q86YN6
        target: MESH:D008074
    -   key: increases activity of
        source: MESH:D009525
        target: UniProt:P49019
    -   key: decreases synthesis of
        source: UniProt:P49019
        target: MESH:D000242
    -   key: decreases degradation of
        source: MESH:D009525
        target: UniProt:P02647
    -   key: increases abundance of
        source: UniProt:P02647
        target: MESH:D008076
    -   key: manifestation of
        source: MESH:D008076
        target: MESH:D006937
    -   key: increases degradation of
        source: MESH:D014280
        target: UniProt:P04114
    -   key: decreases synthesis of
        source: UniProt:P04114
        target: MESH:D008074
    -   key: manifestation of
        source: MESH:D008074
        target: MESH:D006937
    multigraph: true
    nodes:
    -   id: MESH:D009525
        label: Drug
        name: Nicotinic acid
    -   id: UniProt:O75907
        label: Protein
        name: Diacylglycerol O-acyltransferase 2 (DGAT2)
    -   id: REACT:R-HSA-75109
        label: Pathway
        name: Triglyceride biosynthesis
    -   id: MESH:D014280
        label: ChemicalSubstance
        name: Triglyceride
    -   id: MESH:D008076
        label: ChemicalSubstance
        name: HDL Cholesterol
    -   id: UniProt:P02647
        label: Protein
        name: Apolipoprotein A1
    -   id: UniProt:P49019
        label: Protein
        name: Hydroxycarboxylic acid receptor 3
    -   id: UniProt:Q86YN6
        label: Protein
        name: PPARg coactivator-1b
    -   id: MESH:D008074
        label: ChemicalSubstance
        name: Lipoprotein
    -   id: UniProt:P02656
        label: Protein
        name: Apolipoprotein C3
    -   id: MESH:D005230
        label: ChemicalSubstance
        name: Free fatty acids
    -   id: MESH:D000242
        label: ChemicalSubstance
        name: Cyclic AMP
    -   id: UniProt:Q8TDS4
        label: Protein
        name: Hydroxycarboxylic acid receptor 2
    -   id: UniProt:P04114
        label: Protein
        name: Apolipoprotein B
    -   id: MESH:D008074
        label: ChemicalSubstance
        name: Lipoprotein
    -   id: MESH:D006937
        label: Disease
        name: Hypercholesterolemia
    reference: https://go.drugbank.com/drugs/DB00627#mechanismofaction  https://en.wikipedia.org/wiki/Niacin#Mechanisms doi:10.1194/jlr.S092007
-   directed: true
    graph:
        drug: Nicotinic acid
        drugbank: DB:DB00627
        drug_mesh: MESH:D009525
        disease: Hyperlipidemia
        disease_mesh: MESH:D006949
    links:
    -   key: decreases activity of
        source: MESH:D009525
        target: UniProt:O75907
    -   key: negatively regulates
        source: UniProt:O75907
        target: REACT:R-HSA-75109
    -   key: decreases abundance of
        source: REACT:R-HSA-75109
        target: MESH:D014280
    -   key: increases activity of
        source: MESH:D009525
        target: UniProt:Q8TDS4
    -   key: decreases synthesis of
        source: UniProt:Q8TDS4
        target: MESH:D000242
    -   key: decreases abundance of
        source: MESH:D000242
        target: MESH:D005230
    -   key: decreases expression of
        source: MESH:D005230
        target: UniProt:P02656
    -   key: decreases synthesis of
        source: UniProt:P02656
        target: MESH:D008074
    -   key: decreases expression of
        source: MESH:D005230
        target: UniProt:Q86YN6
    -   key: decreases synthesis of
        source: UniProt:Q86YN6
        target: MESH:D008074
    -   key: increases activity of
        source: MESH:D009525
        target: UniProt:P49019
    -   key: decreases synthesis of
        source: UniProt:P49019
        target: MESH:D000242
    -   key: decreases degradation of
        source: MESH:D009525
        target: UniProt:P02647
    -   key: increases abundance of
        source: UniProt:P02647
        target: MESH:D008076
    -   key: manifestation of
        source: MESH:D008076
        target: MESH:D006949
    -   key: increases degradation of
        source: MESH:D014280
        target: UniProt:P04114
    -   key: decreases synthesis of
        source: UniProt:P04114
        target: MESH:D008074
    -   key: manifestation of
        source: MESH:D008074
        target: MESH:D006949
    multigraph: true
    nodes:
    -   id: MESH:D009525
        label: Drug
        name: Nicotinic acid
    -   id: UniProt:O75907
        label: Protein
        name: Diacylglycerol O-acyltransferase 2 (DGAT2)
    -   id: REACT:R-HSA-75109
        label: Pathway
        name: Triglyceride biosynthesis
    -   id: MESH:D014280
        label: ChemicalSubstance
        name: Triglyceride
    -   id: MESH:D008076
        label: ChemicalSubstance
        name: HDL Cholesterol
    -   id: UniProt:P02647
        label: Protein
        name: Apolipoprotein A1
    -   id: UniProt:P49019
        label: Protein
        name: Hydroxycarboxylic acid receptor 3
    -   id: UniProt:Q86YN6
        label: Protein
        name: PPARg coactivator-1b
    -   id: MESH:D008074
        label: ChemicalSubstance
        name: Lipoprotein
    -   id: UniProt:P02656
        label: Protein
        name: Apolipoprotein C3
    -   id: MESH:D005230
        label: ChemicalSubstance
        name: Free fatty acids
    -   id: MESH:D000242
        label: ChemicalSubstance
        name: Cyclic AMP
    -   id: UniProt:Q8TDS4
        label: Protein
        name: Hydroxycarboxylic acid receptor 2
    -   id: UniProt:P04114
        label: Protein
        name: Apolipoprotein B
    -   id: MESH:D008074
        label: ChemicalSubstance
        name: Lipoprotein
    -   id: MESH:D006949
        label: Disease
        name: Hyperlipidemia
    reference: https://go.drugbank.com/drugs/DB00627#mechanismofaction  https://en.wikipedia.org/wiki/Niacin#Mechanisms doi:10.1194/jlr.S092007
